Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-548-5 | CAS number: 1621424-03-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 - 22 Nov 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Adopted in 2019
- Deviations:
- yes
- Remarks:
- Demonstration of appropriate morphology of the tissues is not provided by the RhE model developer/vendor.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Slovak National Accrediatation Service, Bratislava, Slovak Republic
Test material
- Reference substance name:
- {[4-({dimethyl[3-(prop-2-enamido)propyl]azaniumyl}methyl)phenyl]methyl}dimethyl[3-(prop-2-enamido)propyl]azanium dichloride
- EC Number:
- 812-548-5
- Cas Number:
- 1621424-03-0
- Molecular formula:
- C24H40Cl2N4O2
- IUPAC Name:
- {[4-({dimethyl[3-(prop-2-enamido)propyl]azaniumyl}methyl)phenyl]methyl}dimethyl[3-(prop-2-enamido)propyl]azanium dichloride
Constituent 1
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EpiDerm SIT (EPI-200), MatTek In Vitro Life Science Laboratories, Slovak Republic
- Justification for test system used:
- The EpiDerm model is a three-dimensional reconstructed human epidermal (RhE) model, comprised of non-transformed human-derived epidermal keratinocytes, which have been cultured to form a multilayered, highly differentiated model of the human epidermis. The test substance is applied topically onto the tissue and subsequently cytotoxicity is measured. Irritant substances are identified by their ability to decrease cell viability (as determined by using the MTT reduction assay) below defined threshold levels. The EpiDerm skin irritation test allows discrimination between substances requiring classification and labelling (EU GHS category 1 or 2) and nonirritants according to the EU GHS classification system.
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- Shortly before application of the test substance the tissue surface was moistened with DPBS to improve contact of the tissue surface with the test item.
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ skin irritation test (SIT) (EPI-200), MatTek In Vitro Life Science Laboratories, Slovak Republic
- Tissue batch number(s): Lot no. 30836; Keratinocyte strain: 00267
- Production date: 20 Nov 2019 (Certificate of Analysis from MatTek)
- Delivery date: 18 Nov 2019
- Date of initiation of testing: 19 Nov 2019
Comment on the production date and experimental starting date: The tissue supplier states that the production date for the tissues produced by MatTek IVLSL is Monday. The lab performs preQC and if the tissues do not fulfil the quality control criteria the tissues are not shipped to the customers. To obtain the real life data for the tissues shipped to the customers, MatTek mimics the shipment conditions and therefore performs the quality controls on Tuesdays with quality control measurements on Wednesdays. Therefore the certificates of analysis for the tissues are issued on Wednesdays. This is the standard procedure for RhE tissues currently produced at MatTek IVLSL.
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: After dosing, all plates were transferred to the humidified incubator at 37 °C for 35 ± 1 min. After 35 min, all plates were removed from the incubator and placed into the sterile hood (room temperature) until the period of 60 min incubation was completed.
- Temperature of post-treatment incubation: 37 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: Each tissue was rinsed with sterile DPBS, filling and emptying the tissue insert 15 times to remove any residual test material, then was submerged 3 times in 150 mL of DPBS. Finally, the tissues were rinsed once from inside and once from outside with sterile DPBS and each insert was blotted on sterile blotting paper and transferred to new 6-well plates prefilled with 0.9 mL of fresh assay medium.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL MTT solution, 0.3 mL/well
- Incubation time: 3 h
- Spectrophotometer: Dynex MRX II
- Wavelength: 540 nm
- Filter: without reference filter
FUNCTIONAL MODEL CONDITIONS
- Viability: The quality of the EpiDerm™ SIT tissue was assessed by an MTT cell viability test. The OD (540 - 570 nm) was 2.002 ± 0.169 (acceptance criteria: 1.0 - 3.0).
- Barrier function: The barrier function was assessed by determination of the exposure time required to reduce tissue viability by 50% (ET-50) following application of 100 µL 1% Triton X-100. The ET-50 value was determined to be 4.85 h (acceptance criteria: 4.77 - 8.72 h).
- Contamination: The cells used to produce the EpiDerm™ tissue were screened for the presence of HIV-1 virus, Hepatitis B virus, Hepatitis C virus, bacteria, yeast and other fungi. No contamination was detected.
MTT DIRECT INTERFERENCE
Tests for interference of the test substance with the MTT assay were performed. First, the test substance was incubated for 60 min in purified water. The colour of the mixture was unchanged. It was concluded that the test substance does not have the potential to stain tissue. Second, the test substance was incubated for 60 min in MTT medium. The colour of MTT solution remained unchanged. It was concluded that the test substance did not reduce MTT directly.
Since the test substance did not directly reduce the MTT solution, an additional functional check was not performed.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: Single experiment.
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the mean tissue viability after 60 min exposure is less than or equals 50%.
- The test substance is considered to be non-irritant to skin if the mean tissue viability after 60 min exposure is > 50%.
DEMONSTRATION OF TECHNICAL PROFICIENCY TESTING:
Demonstration of proficiency is stated in amendment No. 1 to the final report. The laboratory demonstrates technical proficiency by the non-classified substances (UN GHS no Category) and classified substances (UN GHS Category 2) indicated by the OECD 439 (version 25 Jul 2015) in vitro skin irritation test. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 25 mg
VEHICLE
- The test substance was applied without vehicle. Shortly before application of the test substance the tissue surface was moistened with 25 µL of sterile DPBS to improve contact of the tissue surface with the test substance.
NEGATIVE CONTROL
- Amount applied: 30 µL of DPBS
POSITIVE CONTROL
- Amount applied: 30 µL
- Concentration: 5% SDS - Duration of treatment / exposure:
- 60 min (35 min at 37 °C and 25 min at RT)
- Duration of post-treatment incubation (if applicable):
- 42 h
- Number of replicates:
- Triplicates for each treatment and control group were used.
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean value of 3 tissues
- Run / experiment:
- 60 min exposure
- Value:
- 98.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Direct-MTT reduction: The test substance did not directly reduce MTT.
- Colour interference with MTT: The test substance did not change the colour, when mixed with deionised water and thus passed the colour interference pre-test.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, the mean OD of the tissue replicates treated with the negative control was ≥ 0.8 and ≤ 2.8. The mean OD of the negative control was 1.334.
- Acceptance criteria met for positive control: Yes, the mean viability of the tissue replicates treated with the positive control for 60 min was < 20%. The mean viability of tissues treated with the positive control was 4.2%.
- Acceptance criteria met for variability between replicate measurements: Yes, the SD calculated from individual % tissue viabilities of three identically treated replicates was 5.49, i.e. < 18%. The coefficient of variation was 5.56.
Any other information on results incl. tables
Table 1. Skin irritation potential of FV-1295 after 60-minute exposure in reconstructed human epidermal model EpiDerm SIT
Test item | Tissue No. | OD - blank corrected | OD - mean | SD of OD | Cell viability (%) | Mean cell viability (%) | SD of cell viability | CV (%) | Classification |
Negative control DPBS |
1 | 1.312 | 1.334 | 0.025 | 98.3 | 100 | 1.91 | 1.91 | Non-irritant |
2 | 1.329 | 99.6 | |||||||
3 | 1.362 | 102.1 | |||||||
Positive control 5 % SDS |
1 | 0.058 | 0.056 | 0.002 | 4.3 | 4.2 | 0.15 | 3.57 | Irritant |
2 | 0.054 | 4.0 | |||||||
3 | 0.056 | 4.2 | |||||||
FV-1295 | 1 | 1.397 | 1.318 | 0.073 | 104.7 | 98.8 | 5.49 | 5.56 | Non-irritant |
2 | 1.306 | 97.9 | |||||||
3 | 1.252 | 93.8 |
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- The determined viability of FV-1295-treated tissue culture fulfilled the criteria for non-irritancy.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.